Promega Corporation

Genetically Encoded Luciferase Biosensors for Screening Potentially Difficult Targets...

Genetically Encoded Luciferase Biosensors for Screening Potentially Difficult Targets Scientific Poster




Frank Fan, Brock Binkowski, Susan Wigdal, Braeden Butler, Ken Lewis, Pete Stecha, Keith Wood
Promega Corporation, 2800 Woods Hollow Rd., Madison, WI 53711

Many potentially druggable targets have proven to be difficult to adapt to many screening programs, especially as cell-based assays. In recent years we have developed new bioluminescent-based assays to address such challenges. Bioluminescent assays are uniquely suited for high-throughput screening due to their inherent high sensitivity, wide dynamic range and low susceptibility to compound interference. In this report, we present a new biosensor technology to address two popular targets in pharmaceutical screening: Proteases and GPCRs.

Document Icon Download the poster PDF (185kb)

  • Part# PS067
  • Printed in USA.

Prefer a different language?

Your country is set to Poland. Your language is set to polski. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.